logo-loader
NASDAQ:ADAP

Adaptimmune Therapeutics PLC

Market:
NASDAQ
Market Cap:
$1.23 billion
Price
7.93 USD
Change
-8.96%
52 weeks high
13.39
52 weeks low
0.71

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.